Kneu Health Raises $5.6M Seed Funding for Neurological Monitoring

Kneu Health has announced it has successfully raised $5.6 million in new investment capital from investors. This significant funding round marks a key milestone for the digital health company, which specializes in advanced solutions for neurological conditions. The investment underscores confidence in Kneu Health's innovative approach to monitoring and managing complex health challenges through accessible technology. The company's core offering transforms standard smartphones into clinical-grade monitors, initially focusing on conditions such as Parkinson’s and dementia. Kneu Health’s technology, developed from over a decade of Oxford research, captures subtle yet crucial changes in movement, cognition, and overall wellbeing. This capability provides objective insights that move beyond subjective self-reporting, aiming to empower individuals living with neurological conditions, support clinicians in delivering more personalized care pathways, and assist health systems in both the UK and US with reducing operational pressures while simultaneously improving patient outcomes. This newly secured capital will be strategically deployed to accelerate Kneu Health’s ambitious growth initiatives. The company plans to use the funds to further enhance its technology platform, scale its operational capabilities, and expand its market presence. The investment is central to Kneu Health’s mission of making advanced neurological monitoring more widely available and integrated into routine care. Looking ahead, Kneu Health is poised to continue its trajectory of innovation and expansion. The company aims to broaden the scope of its platform, reach a greater number of patients and healthcare providers, and solidify its position as a leader in digital neurological health. This funding round is expected to enable Kneu Health to significantly advance its efforts in transforming neurological care globally.